These sleep issues can contribute to the daytime fatigue many people experience while adjusting to treatment
[1] [2] Common adverse effects that women should anticipate include: Gastrointestinal symptoms (nausea, vomiting, diarrhoea, constipation) affecting up to 40% of users, typically most pronounced during dose escalation [1] [2] Injection site reactions such as redness or itching Headache and dizziness Fatigue , which might be particularly relevant for women already experiencing tiredness from fibroid-related anaemia Serious but rare risks include pancreatitis (inflammation of the pancreas), gallbladder disease, and hypoglycaemia, particularly in those taking other glucose-lowering medications
Similar content being viewed by others Introduction An estimated 29.5 million or 10.6% of Americans ages 12 and older had an alcohol use disorder (AUD) in 2021 1
Based on the current research, berberine has the most evidence for metabolic health benefits among compounds marketed as GLP-1 boosters
This suggests renal protective effects that extend beyond blood sugar control